Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122625) titled 'Thoracic Lymphadenopathy in LDCT Lung Cancer Screening: Clinical Significance and Management Strategies' on April 15.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: West China Hospital of Sichuan University
Condition:
The etiologies of thoracic lymphadenopathy detected through LDCT lung cancer screening include sarcoidosis, tuberculosis, malignant lymph node metastasis, among others
Intervention:
Observational Group (thoracic lymphadenopathy/ non-thoracic lymphadenopathy):None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-16
Target Sample...